Nov 29, 2021 10:25am EST BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
Nov 29, 2021 8:00am EST ÄÐÈ˹¬µî Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference
Oct 28, 2021 4:15pm EDT ÄÐÈ˹¬µî Reports 2021 Third Quarter Business Highlights and Financial Results
Sep 24, 2021 4:24pm EDT Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Sep 14, 2021 8:00am EDT LeaderMed Group and ÄÐÈ˹¬µî Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories
Aug 30, 2021 4:17pm EDT ÄÐÈ˹¬µî Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
Aug 26, 2021 9:30am EDT Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program